Septerna, Inc. (SEPN) Stock News & Chart | StockAdder

(SEPN)

Septerna, Inc.

Stock chart and latest news for Septerna, Inc., tracked under Pharmaceuticals, Biotechnology & Life Sciences in the Health Care sector.

Chart powered byTradingView— professional charts for every trader.Try it free →

Septerna, Inc. News

PRO

Septerna starts human testing of an oral drug for a lifelong disorder

Apr 13, 2026 TipRanks

Septerna Begins Phase 1 Trial of Oral SEP-479

Apr 13, 2026 Zacks Investment Research

SEPN: Septerna, Inc. - Detailed Earnings Estimates

Apr 8, 2026 Investing.com UK

H.C. Wainwright reiterates Septerna stock rating on trial start

Apr 14, 2026 Yahoo Finance

Septerna, Inc. (SEPN) Reports Q4 Loss, Tops Revenue Estimates

Mar 9, 2026 Seeking Alpha

SEP-631 Phase 1 Readout: The Catalyst Set To Drive Septerna In 2026 (NASDAQ:SEPN)

Feb 25, 2026 Benzinga

Septerna Stock: A Deep Dive Into Analyst Perspectives (5 Ratings)

Mar 2, 2026 The Globe and Mail

Analysts’ Top Technology Picks: CrowdStrike Holdings (CRWD), Septerna, Inc. (SEPN)

Feb 25, 2026 Yahoo Finance

Why Septerna (SEPN) Is Up 28.5% After Posting a Surprise Profit and Analyst Upgrades

Nov 17, 2025 Stock Titan

Septerna mast cell pill sharply curbs wheals in Phase 1

Mar 9, 2026 Seeking Alpha

Septerna's Novo Partnership Begins To Transform The Story (NASDAQ:SEPN)

Nov 25, 2025 The Globe and Mail

Analysts Conflicted on These Technology Names: Fortinet (FTNT), Septerna, Inc. (SEPN) and Oracle (ORCL)